ROCKET PHARMACEUTICALS, INC. (RCKT)

Typically moves ±2.70% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

ROCKET PHARMACEUTICALS, INC. (RCKT) has reported earnings 17 times since May 10, 2021. The stock moves an average of ±2.70% the day after reporting, closing higher 52.9% of the time. Its largest post-earnings gain was +10.6% (Feb 26, 2026) and its largest decline was -7.44% (Aug 07, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How RCKT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±2.70%

Positive %

52.9%

Negative %

47.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☽ POST	-2.55%	open_in_new
Feb 26, 2026	☽ POST	+10.6%	open_in_new
Nov 06, 2025	☽ POST	-1.86%	open_in_new
Aug 07, 2025	☽ POST	-7.44%	open_in_new
May 08, 2025	☽ POST	-0.71%	open_in_new
Feb 27, 2025	☽ POST	+0.53%	open_in_new
Nov 07, 2024	☽ POST	+1.16%	open_in_new
Aug 05, 2024	☽ POST	+0.85%	open_in_new
May 06, 2024	☽ POST	+0.69%	open_in_new
Feb 26, 2024	☽ POST	+3.19%	open_in_new
Feb 27, 2023	☽ POST	+4.06%	open_in_new
Nov 03, 2022	☽ POST	-4.33%	open_in_new
Aug 08, 2022	☽ POST	+2.46%	open_in_new
Feb 24, 2022	☽ POST	+0.34%	open_in_new
Nov 04, 2021	☽ POST	-0.36%	open_in_new
Aug 09, 2021	☽ POST	-1.78%	open_in_new
May 10, 2021	☽ POST	-3%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±2.70%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 28 →

Funds holding

$95726975

Total value held

Buying

18 added · 9 reduced

Blackrock, Inc.

$33939951 +26.67%

Citigroup Inc

$16640184 -7.26%

Goldman Sachs Group Inc

$10169120 +59.77%

Federated Hermes, Inc.

$7880388 NEW BUY

Jpmorgan Chase & Co

$6700952 +149.73%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
25-NSE	20260902	open_in_new SEC.gov
8-K	20260827	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
4	20260817	open_in_new SEC.gov
4	20260817	open_in_new SEC.gov
144	20260813	open_in_new SEC.gov

Frequently asked about RCKT earnings

When does ROCKET PHARMACEUTICALS, INC. report earnings next? expand_more

ROCKET PHARMACEUTICALS, INC. (RCKT)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RCKT stock move after earnings? expand_more

Over 17 reports, RCKT has moved an average of ±2.70% the session after earnings, closing higher 52.9% of the time.

What was RCKT's biggest post-earnings move? expand_more

RCKT's largest post-earnings gain on record was +10.6% on Feb 26, 2026, and its largest decline was -7.44% on Aug 07, 2025.

Where can I find ROCKET PHARMACEUTICALS, INC.'s SEC filings? expand_more

All of ROCKET PHARMACEUTICALS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.